George Shenouda

870 total citations
40 papers, 555 citations indexed

About

George Shenouda is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiation. According to data from OpenAlex, George Shenouda has authored 40 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Otorhinolaryngology and 10 papers in Radiation. Recurrent topics in George Shenouda's work include Head and Neck Cancer Studies (14 papers), Advanced Radiotherapy Techniques (10 papers) and Glioma Diagnosis and Treatment (9 papers). George Shenouda is often cited by papers focused on Head and Neck Cancer Studies (14 papers), Advanced Radiotherapy Techniques (10 papers) and Glioma Diagnosis and Treatment (9 papers). George Shenouda collaborates with scholars based in Canada, United States and Lebanon. George Shenouda's co-authors include Luís Souhami, Bassam Abdulkarim, Valérie Panet-Raymond, Sergio Faria, Horacio Patrocinio, Fabio Cury, Carolyn Freeman, Jan Seuntjens, Marie Duclos and Kevin Petrecca and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

George Shenouda

40 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Shenouda Canada	15	275	224	185	120	95	40	555
Horacio Patrocinio Canada	13	281 1.0×	287 1.3×	185 1.0×	93 0.8×	47 0.5×	31	469
Laura Marucci Italy	17	288 1.0×	165 0.7×	276 1.5×	88 0.7×	231 2.4×	46	711
Pavel V. Houdek United States	15	256 0.9×	299 1.3×	230 1.2×	122 1.0×	26 0.3×	44	614
Y. Niwa Japan	15	475 1.7×	247 1.1×	120 0.6×	26 0.2×	126 1.3×	30	745
Vladimir Avkshtol United States	10	206 0.7×	117 0.5×	97 0.5×	79 0.7×	65 0.7×	28	327
Jinhyun Choi South Korea	14	154 0.6×	109 0.5×	108 0.6×	45 0.4×	36 0.4×	42	465
Dirk Geismar Germany	11	314 1.1×	207 0.9×	114 0.6×	20 0.2×	194 2.0×	25	493
E. Brian Butler United States	8	344 1.3×	328 1.5×	208 1.1×	14 0.1×	160 1.7×	13	619
Wolfgang W. Baus Germany	11	408 1.5×	438 2.0×	341 1.8×	75 0.6×	14 0.1×	23	691
Maria Rosa La Porta Italy	16	423 1.5×	532 2.4×	305 1.6×	27 0.2×	83 0.9×	38	869

Countries citing papers authored by George Shenouda

Since Specialization

Citations

This map shows the geographic impact of George Shenouda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Shenouda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Shenouda more than expected).

Fields of papers citing papers by George Shenouda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Shenouda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Shenouda. The network helps show where George Shenouda may publish in the future.

Co-authorship network of co-authors of George Shenouda

This figure shows the co-authorship network connecting the top 25 collaborators of George Shenouda. A scholar is included among the top collaborators of George Shenouda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Shenouda. George Shenouda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sadeghi, Nader, Keith Richardson, Marco A. Mascarella, et al.. (2024). Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus–Related Oropharyngeal Cancer. JAMA Otolaryngology–Head & Neck Surgery. 151(2). 128–128. 1 indexed citations

Faye, Mame Daro, Jacob C. Easaw, Paula de Robles, et al.. (2023). Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-Oncology Advances. 5(1). vdad106–vdad106. 5 indexed citations

Khosrow‐Khavar, Farzin, Marie‐Christine Guiot, Bassam Abdulkarim, et al.. (2022). Is Postoperative Radiotherapy Needed in the Management of Adult Craniopharyngiomas?. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(3). 428–434. 2 indexed citations

Lo, Christopher, Zeev Rosberger, Saul Frenkiel, et al.. (2022). Biopsychosocial Markers of Body Image Concerns in Patients with Head and Neck Cancer: A Prospective Longitudinal Study. Current Oncology. 29(7). 4438–4454. 9 indexed citations

Wong, Stuart J., Pedro A. Torres‐Saavedra, Nabil F. Saba, et al.. (2021). TRYHARD, a randomized phase II trial (RTOG Foundation 3501) of concurrent accelerated radiation plus cisplatin (cis) with or without lapatinib (Lap) for stage III- IV Non-HPV head and neck carcinoma (HNC).. Journal of Clinical Oncology. 39(15_suppl). 6014–6014. 1 indexed citations

Mell, Loren K., Hanjie Shen, Phuc Félix Nguyen‐Tan, et al.. (2019). Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clinical Cancer Research. 25(23). 7078–7088. 18 indexed citations

Vallières, Martin, et al.. (2019). Magnetic Resonance Imaging Texture Analysis Predicts Recurrence in Patients with Nasopharyngeal Carcinoma. Canadian Association of Radiologists Journal. 70(4). 394–402. 12 indexed citations

Santos, Fabiano, George Shenouda, Kevin Petrecca, et al.. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Journal of Neuro-Oncology. 132(3). 419–426. 61 indexed citations

Shenouda, George, Luís Souhami, Kevin Petrecca, et al.. (2016). A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 97(3). 487–494. 35 indexed citations

10.

Kish, Julie A., Qiang Zhang, Corey J. Langer, et al.. (2015). The effect of age on outcome in prospective, phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- chemotherapy in locally advanced (LA) head and neck cancer (HNC).. Journal of Clinical Oncology. 33(15_suppl). 6003–6003. 9 indexed citations

11.

Patel, Nita, Sergio Faria, Fabio Cury, et al.. (2013). Hypofractionated Radiation Therapy (66 Gy in 22 Fractions at 3 Gy per Fraction) for Favorable-Risk Prostate Cancer: Long-term Outcomes. International Journal of Radiation Oncology*Biology*Physics. 86(3). 534–539. 23 indexed citations

12.

Chung, Christine H., Qiang Zhang, Christina S. Kong, et al.. (2013). p16 expression as a human papillomavirus (HPV)-independent prognostic biomarker in non-oropharyngeal squamous cell carcinoma (non-OPSCC).. Journal of Clinical Oncology. 31(15_suppl). 6007–6007. 9 indexed citations

13.

Shenouda, George, Michael D. Evans, Magdi Mansour, et al.. (2013). Intraoperative Sonographically Assisted Radioactive Iodine 125 Plaque Brachytherapy for Choroidal Melanoma. Journal of Ultrasound in Medicine. 32(6). 995–1001. 5 indexed citations

14.

Waldron, John, Wendy R. Parulekar, Brian O’Sullivan, et al.. (2012). A phase III study of standard fractionation radiotherapy with concurrent high-dose cisplatin versus accelerated fractionation radiotherapy (RT) with panitumumab in patients with locally advanced stage III and IV squamous cell carcinoma of the head and neck (SCCHN) (NCIC Clinical Trials Group HN.6).. Journal of Clinical Oncology. 30(15_suppl). TPS5600–TPS5600. 3 indexed citations

15.

Pra, Alan Dal, C Corriveau, Chaim Edelstein, et al.. (2011). Stereotactic Fractionated Radiotherapy in the Treatment of Juxtapapillary Choroidal Melanoma: The McGill University Experience. International Journal of Radiation Oncology*Biology*Physics. 81(4). e455–e462. 26 indexed citations

16.

Faria, Sergio, Fabio Cury, Marc David, et al.. (2010). Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(3). 805–810. 33 indexed citations

17.

Parker, William, Horacio Patrocinio, Luís Souhami, et al.. (2007). An Assessment of PTV Margin Definitions for Patients Undergoing Conformal 3D External Beam Radiation Therapy for Prostate Cancer Based on an Analysis of 10,327 Pretreatment Daily Ultrasound Localizations. International Journal of Radiation Oncology*Biology*Physics. 67(5). 1430–1437. 37 indexed citations

18.

Schwartz, M. William, et al.. (2005). Energy modulated electron therapy using a few leaf electron collimator in combination with IMRT and 3D‐CRT: Monte Carlo‐based planning and dosimetric evaluation. Medical Physics. 32(9). 2976–2986. 37 indexed citations

19.

Roberge, David, et al.. (2004). Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy. Radiotherapy and Oncology. 74(1). 71–73. 4 indexed citations

20.

Thomson, David M., et al.. (1988). Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens. Clinical Immunology and Immunopathology. 49(2). 231–241. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact